P/E ratio for CompuGroup Medical (COP.DE)
P/E ratio as of September 2023 (TTM): 21.1
According to CompuGroup Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 21.0692. At the end of 2021 the company had a P/E ratio of 54.7.
P/E ratio history for CompuGroup Medical from 2010 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 54.7 | -0.43% |
| 2020 | 55.0 | 16.4% |
| 2019 | 47.2 | 115.07% |
| 2018 | 22.0 | -74.72% |
| 2017 | 86.9 | 100.72% |
| 2016 | 43.3 | -1.42% |
| 2015 | 43.9 | 16.91% |
| 2014 | 37.5 | -2.58% |
| 2013 | 38.5 | 62.01% |
| 2012 | 23.8 | -50.78% |
| 2011 | 48.3 | 44.15% |
| 2010 | 33.5 | 8.02% |
| 2009 | 31.0 | -69.16% |
| 2008 | 101 | 256.21% |
| 2007 | 28.3 | 155.13% |
| 2006 | 11.1 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.